Quell Therapeutics

Transforming lives in immune mediated disease

Transforming lives in immune mediated disease

Quell Therapeutics is a clinical-stage company, fuelled by curiosity and discovery, on a mission to make life better for those battling severe immune and inflammatory disease

Quell Slider 2

Discover our industry-leading platform and technology

050 A0689
050 A0674
Glassy tcell

WE ARE PIONEERS

At Quell, we are reimagining the treatment of severe immune disorders.

Our goal is to leverage the unique potential of Tregs to reinstate immune balance, bringing long-lasting control to patients with severe immune diseases.

The Problem

When immune tolerance is lost

Quell patient
T cell quell gen
Person jacket

Each day, the immune system delicately navigates the balance between self-tolerance and protection against external threats. 

When this equilibrium is broken, it can lead to autoimmunity, chronic inflammation, or, in the case of organ transplantation, graft rejection. 

Within this intricate interplay, Tregs serve as the pivotal regulators of tolerance - dampening immune responses and applying the brakes to prevent autoreactivity, inflammation and subsequent tissue damage.

Through engineering a patient's own Tregs, Quell aims to develop treatments with the potential to transform and to save lives.

Discover our Science

Our Platform

Delivering the most functionally stable and potent targeted Tregs

with the optimal cell product at our core and a suite of innovative technologies to ensure continued trailblazing progress

Team & Culture

Empowered by our people

At Quell we present a calling for visionaries looking to shape the future of healthcare

QOS 2485 edit
002 A0828
002 A0824
050 A0697
Labcoat picture v4
Person drinking